Healthy volunteers needed to test new asthma drug copycat
NCT ID NCT07327697
First seen Jan 11, 2026 · Last updated May 20, 2026 · Updated 25 times
Summary
This early-stage study tests a new drug called QL2302 in 178 healthy adults aged 18 to 45. It compares how the body processes QL2302 versus the approved drug Tezspire, and checks for side effects and immune responses after a single dose. The goal is to see if QL2302 works similarly to Tezspire, which is used for severe asthma.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.